LI Xiaowei
University of South China, Hengyang, Hunan 421001, China;Department of Cardiology, Guangdong Second Provincial General Hospital, University of South China, Guangzhou, Guangdong 510317, ChinaFENG Shujun
University of South China, Hengyang, Hunan 421001, China;Department of Cardiology, the First Peoples Hospital of Chenzhou, University of South China, Chenzhou, Hunan 423000, ChinaZHOU Fenghua
School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, ChinaJIN Wen
Department of Cardiology, Guangdong Second Provincial General Hospital, University of South China, Guangzhou, Guangdong 510317, ChinaZHAO Yiqiao
Department of Cardiology, Guangdong Second Provincial General Hospital, University of South China, Guangzhou, Guangdong 510317, China1.University of South China, Hengyang, Hunan 421001, China;2.Department of Cardiology, Guangdong Second Provincial General Hospital, University of South China, Guangzhou, Guangdong 510317, China;3.Department of Cardiology, the First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan 423000, China;4.School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China)
R541.4
LI Xiaowei, FENG Shujun, ZHOU Fenghua, JIN Wen, ZHAO Yiqiao. Advances in miR-34a:its roles and mechanisms in cardiovascular disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2019,27(7):624-628.
Copy